Sutter reported a $236 million loss from operations in the three months ended March 31. This compares to $38 million income from operations in the same period last year.
In addition, Sutter reported investment losses of $21 million and unrealized losses on investments of $818 million in the first quarter.
Sutter saw its operating revenue reach $3.2 billion in the first quarter, down from $3.3 billion in the same period in 2019. Its operating expenses rose to $3.4 billion in the first quarter of this year, compared to $3.3 billion in the same period one year prior.
Sutter said it began losing operating revenue as patient volume dipped in mid-March after the shelter-in-place orders and suspension of nonemergency healthcare services in response to the COVID-19 pandemic.
Sutter said that adjusting the system to respond to the COVID-19 pandemic was costly, and continues to be costly. To help offset those costs, Sutter has received more than $200 million in provider relief funds from HHS. It also received $1 billion in accelerated and advance payments from CMS.
More articles on healthcare finance:
Mass General Brigham posts $1.6B loss in Q2
New York hospital lays off 70 after denial of federal funding
Hospitals blast CMS decision to double down on price transparency
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
